KRAS and pancreatic neoplasm: What is interesting about KRAS mutations is that in pancreatic cancer the most common mutation is one amino-acid substitution in position 12 of the KRAS protein, leading to a glycine (G) to aspartic acid (D) substitution, although other variants, such as G to V are also common [14].